Similar articles

• Ocular changes in monkeys fed with sanguinarine and other substances.

  LEACH EH. LEACH EH. Trans Ophthalmol Soc U K. 1955;75:425-30. Trans Ophthalmol Soc U K. 1955. PMID: 13360932 No abstract available.
• Isolation from argemone oil of dihydrosanguinarine and sanguinarine; toxicity of sanguinarine.

  SARKAR SM. SARKAR SM. Nature. 1948 Aug 14;162(4111):265. doi: 10.1038/162265a0. Nature. 1948. PMID: 18877104 No abstract available.
• Argemone oil, sanguinarine, and epidemic-dropsy glaucoma.

  HAKIM SA. HAKIM SA. Br J Ophthalmol. 1954 Apr;38(4):193-216. doi: 10.1136/bjo.38.4.193. Br J Ophthalmol. 1954. PMID: 13149763 Free PMC article. No abstract available.
• Assessing the risk of epidemic dropsy from black salve use.

  Croaker A, King GJ, Pyne JH, Anoopkumar-Dukie S, Liu L. Croaker A, et al. J Appl Toxicol. 2018 Oct;38(10):1274-1281. doi: 10.1002/jat.3619. Epub 2018 Mar 30. J Appl Toxicol. 2018. PMID: 29603306 Review.
• Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil.

  Das M, Khanna SK. Das M, et al. Crit Rev Toxicol. 1997 May;27(3):273-97. doi: 10.3109/10408449709089896. Crit Rev Toxicol. 1997. PMID: 9189656 Review.